North America Proton Therapy Market By Type of System (Single Room System and Multi-Room System), By Application (Paediatric Cancer, Head & Neck Cancer, Prostate Cancer, Lung Cancer, Gastro-Intestinal Cancer, Brain Cancer and Others), By End-User (Hospitals, Radiotherapy Centres and Others) and Country  

Purchase Option

$ 3100
$ 4600
$ 6900

North America Proton Therapy Market is expected to grow at a significant CAGR of 12.6% from 2023 to 2029. Proton therapy is also known as proton beam radiation therapy. Proton is a positively charged particle, and in high energy levels protons can destroy the cancer cells. Proton therapy is a non-invasive procedure in which proton radiation used to treat cancer. Proton therapy is a type of external beam radiation therapy, which painlessly delivers radiation through the skin from outside of the body. For the treatment of cancer, proton therapy may be prescribed alone or along with the other treatments such as surgery, chemotherapy, general radiation therapy and or immunotherapy. The report studies market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the market report includes regulatory scenario and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed North America Proton Therapy market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Opportunities)

North America Proton Therapy Market Dynamics

North America proton therapy market is mainly driven by an increase in the adaptation radiation therapies in the treatment of cancer. Addition to this, growing number of radiotherapy centers in North America coupled with the increase in the prevalence of the cancer cases expected to bolster the market growth of North America proton therapy market over the forecast period. However, high-cost treatment and stringent regulatory procedures are expected to act as restraints for the market growth during the forecast period.

North America Proton Therapy Market Segmentation

By Type
  • Single Room System
  • Multi-Room System
By Application
  • Paediatric Cancer
  • Head & Neck Cancer
  • Prostate Cancer
  • Lung Cancer
  • Gastro-Intestinal Cancer
  • Brain Cancer
  • Others
By End User
  • Hospitals
  • Radiotherapy Centres
  • Others

Frequently Asked Questions

2022 is the base year and 2029 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  • Varian Medical Systems (U.S.)
  • Optivus Proton Therapy, Inc. (U.S.)
  • Mevion Medical Systems (U.S.)
  • Advanced Oncotherapy plc (U.K.)
  • ProTom International Inc, (U.S.)
  • ProNova Solutions LLC (U.S.)

Adjacent Markets